Nurse-led Multidisciplinary Precision Care for Patients With Chronic Heart Failure

Not Applicable

Active, not recruiting

• Conditions: Multidisciplinary Communication; Nurse's Role; Chronic Heart Failure

• Registration Number: NCT05987267
• Lead Sponsor: Zhongshan People's Hospital, Guangdong, China

Brief Summary

This study aimed to evaluate the feasibility and effectiveness of a nurse-led multidisciplinary precision care in early cardiac rehabilitation of patients with chronic heart failure, and further to promote the application of nurse-led multidisciplinary precision care.

Detailed Description

Enrolled patients were randomly divided as 1:1 ratio to experimental group and control group, while experimental group received nurse-led multidisciplinary precision care and the control group received standard care according to guidelines. The primary and secondary outcomes were evaluated and analyzed.

Study Timeline

• Study Start: 2021-11-24
• Primary Completion: 2023-04-10
• Study First Submitted: 2023-07-26
• Status Verified: 2023-08
• Study First Submitted QC: 2023-08-03
• Last Update Submitted: 2023-08-03
• Study First Posted: 2023-08-14
• Last Update Posted: 2023-08-14
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

• Aged from 18 to 80 years;
• Conscious, with normal cognitive function and being communicable;
• NYHA heart function class II-IV;
• Patients met the diagnostic criteria of the clinical guidelines for the diagnosis and treatment of heart failure and were diagnosed with chronic heart failure;
• Informed consent was obtained.

Exclusion Criteria

• Patients with congenital heart disease, cardiac shock, or persistent hypotension;
• Patients with severe liver and kidney dysfunction, moderate to severe anemia or coagulation disorders, and other serious systemic complications;
• Patients with a history of mental illness, a state of severe anxiety or depression, cognitive or communication impairments, and inability to communicate and respond to investigations;
• Patients have been involved in other research that would interfere with this study;
• Patients who declined cardiac rehabilitation and signed informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
left ventricular ejection fraction	baseline, pre-intervention, 1 month after intervention, 3 months after intervention
6-minute walking distance	baseline, pre-intervention, 1 month after intervention, 3 months after intervention

Secondary Outcome Measures

Name	Time	Method
Performance Status Score	baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Symptom Check List-90	baseline, pre-intervention, 1 month after intervention, 3 months after intervention
the European Organization for Research and Treatment of Cancer (EORTC) quality-of-life (QoL) questionnaires (QLQ) QLQ-C30 (version 3.0) score Quality of Life	baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Numbers of patients with cardiovascular complications	baseline, pre-intervention, 1 month after intervention, 3 months after intervention

Trial Locations

Locations (1)

Zhongshan City People's Hospital; 🇨🇳 Zhongshan, Guangdong, China